PACB
Pacific Biosciences·NASDAQ
--
--(--)
--
--(--)
Latest data update time: Updated on 2026-02-07
Latest data update time: Updated on 2026-02-07
3.04 / 10Overall Score
NeturalInvestment Rating
3.04 / 10Overall Score
NeturalInvestment Rating
Is PACB a Good Buy Right Now?
- Based on a composite score of 3.04/10, we rate PACB as a Netural. Our analysis breaks down into 0.91/10 for Fundamentals, 3.38/10 for Technicals, and 3.93/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Technical Analysis of PACB?
Is PACB undervalued or overvalued?
Is money flowing into or out of PACB?
Is PACB a Good Buy Right Now?
- Based on a composite score of 3.04/10, we rate PACB as a Netural. Our analysis breaks down into 0.91/10 for Fundamentals, 3.38/10 for Technicals, and 3.93/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Is PACB undervalued or overvalued?
Technical Analysis of PACB?
Is money flowing into or out of PACB?
